[{"id":5992,"regimens":[{"id":11246,"duration":{"id":5302,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8412,"name":"Immunoglobulins, Intravenous","url":"cure-api2.ncats.io/v1/drugs/8412","rxNorm_id":null,"notes":null},"use_drug":[{"id":7672,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11246},{"id":7673,"answer":"In a novel combination with another drug","answer_other":"","regimen":11246},{"id":7674,"answer":"In a novel population (e.g. pediatrics/neonates, pregnant women, immunosuppressed, etc.)","answer_other":"","regimen":11246}],"created":"2020-09-18T17:09:11.309045Z","updated":"2020-09-27T23:04:20.761300Z","dose":"5 grams over 10 hours","frequency":"6 doses, total 30 grams","route":"IV","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":5992},{"id":11247,"duration":{"id":5303,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7425,"name":"Diphenhydramine","url":"cure-api2.ncats.io/v1/drugs/7425","rxNorm_id":null,"notes":null},"use_drug":[{"id":7675,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11247},{"id":7676,"answer":"In a novel combination with another drug","answer_other":"","regimen":11247},{"id":7677,"answer":"In a novel population (e.g. pediatrics/neonates, pregnant women, immunosuppressed, etc.)","answer_other":"","regimen":11247}],"created":"2020-09-18T17:09:11.316682Z","updated":"2020-09-27T23:04:20.767675Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":5992},{"id":11248,"duration":{"id":5304,"approximate_duration":null,"dates_unknown":false},"drug":{"id":9077,"name":"Methylprednisolone","url":"cure-api2.ncats.io/v1/drugs/9077","rxNorm_id":null,"notes":null},"use_drug":[{"id":7678,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11248},{"id":7679,"answer":"In a novel combination with another drug","answer_other":"","regimen":11248},{"id":7680,"answer":"In a novel population (e.g. pediatrics/neonates, pregnant women, immunosuppressed, etc.)","answer_other":"","regimen":11248}],"created":"2020-09-18T17:09:11.322502Z","updated":"2020-09-27T23:04:20.773632Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":5992},{"id":11249,"duration":{"id":5305,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6038,"name":"Aspirin","url":"cure-api2.ncats.io/v1/drugs/6038","rxNorm_id":null,"notes":null},"use_drug":[{"id":7681,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11249},{"id":7682,"answer":"In a novel combination with another drug","answer_other":"","regimen":11249},{"id":7683,"answer":"In a novel population (e.g. pediatrics/neonates, pregnant women, immunosuppressed, etc.)","answer_other":"","regimen":11249}],"created":"2020-09-18T17:09:11.328487Z","updated":"2020-09-27T23:04:20.779261Z","dose":"~39g/kg/day","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":5992}],"site_of_infection":[],"specific_site":[],"how_outcome":[],"how_diagnosis":[{"id":13365,"answer":"Imaging","answer_other":"","report":5992},{"id":13366,"answer":"PCR","answer_other":"","report":5992}],"author_username":"CURE ID Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":3943,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":5992},{"id":3944,"answer":"There is no standard/approved therapy in this patient population","answer_other":"","report":5992}],"adverse_event_outcome":[{"id":44,"answer":"Other Serious or Important Medical Events","report":5992}],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[{"id":263,"answer":"Black or African American","answer_other":""}],"created":"2020-09-18T17:07:48.501746Z","updated":"2020-09-27T23:04:20.753423Z","title":"Incomplete Kawasaki Disease in a Child with Covid-19.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32393680,"doi":"10.1007/s13312-020-1900-0","article_url":"https://pubmed.ncbi.nlm.nih.gov/32393680/","pub_year":2020,"published_authors":"Rivera-Figueroa EI\r\nSantos R\r\nSimpson S\r\nGarg P","article_author_email":"ppgarg@umc.edu","journal":"Indian pediatrics","abstract":"No abstract available","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"1-5 years","sex":"Male","ethnicity":null,"country_contracted":"United States","country_treated":"United States","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Pneumonia","severity":null,"prev_treatment":"","unusual":"co-ocurrence of Kawasiki disease with Covid-19","drug_treatment_features":"He was transferred to the pediatric intensive care unit because of hypotension. He received fluid boluses and intravenous immunoglobulin (IVIG) therapy was begun, which had to be discontinued because of recurring hypotension. He was briefly supported with high flow nasal cannula up to 10 liter for tachypnea and increased work of breathing, which was weaned-off. Once he was hemodynamically stable, IVIG infusion was resumed slowly at 5 grams over 10 hours (2-5 mL/minute) for 6 doses for a total dose of 30 grams (1.8 g/kg) with a different formulation, after pre-medicating with diphenhydramine and methylprednisolone (only for the first dose) and started on medium-dose aspirin (~39 g/kg/ day). The patient recovered on the pediatric floor with supportive therapy for COVID-19 and was discharged after 6 days in the hospital","have_adverse_events":true,"adverse_events":"recurring hypotension - IVIG _ had to be discontinued","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"He had a history of rash, swelling (palms and soles), conjunctivitis, decreased appetite, diarrhea, dysuria, and abdominal pain. He had been treated with cefdinir for positive rapid streptococcal antigen test four days before, without clinical improvement.","previously_treated":"","flagged":false,"other_coinfections":"positive for streptococcal antigen","disease":630,"drugs":[6038,7425,8412,9077]},{"id":6663,"regimens":[{"id":13331,"duration":{"id":7220,"approximate_duration":"2 Days","dates_unknown":true},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":11831,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13331},{"id":11832,"answer":"In a novel combination with another drug","answer_other":"","regimen":13331}],"created":"2020-12-02T22:59:53.403553Z","updated":"2020-12-02T23:12:45.983980Z","dose":"200mg","frequency":"BID","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6663},{"id":13332,"duration":{"id":7221,"approximate_duration":null,"dates_unknown":false},"drug":{"id":5600,"name":"Acetaminophen","url":"cure-api2.ncats.io/v1/drugs/5600","rxNorm_id":null,"notes":null},"use_drug":[{"id":11833,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13332},{"id":11834,"answer":"In a novel combination with another drug","answer_other":"","regimen":13332}],"created":"2020-12-02T22:59:53.411279Z","updated":"2020-12-02T23:12:45.990495Z","dose":"500mg","frequency":"q6h","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6663},{"id":13333,"duration":{"id":7222,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8783,"name":"Lopinavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/8783","rxNorm_id":null,"notes":null},"use_drug":[{"id":11835,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13333},{"id":11836,"answer":"In a novel combination with another drug","answer_other":"","regimen":13333}],"created":"2020-12-02T22:59:53.417740Z","updated":"2020-12-02T23:12:45.996452Z","dose":"400mg","frequency":"BID","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6663},{"id":13334,"duration":{"id":7223,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8787,"name":"Loratadine","url":"cure-api2.ncats.io/v1/drugs/8787","rxNorm_id":null,"notes":null},"use_drug":[{"id":11837,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13334},{"id":11838,"answer":"In a novel combination with another drug","answer_other":"","regimen":13334}],"created":"2020-12-02T22:59:53.424082Z","updated":"2020-12-02T23:12:46.002928Z","dose":"10mg","frequency":"BID","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6663},{"id":13335,"duration":{"id":7224,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7425,"name":"Diphenhydramine","url":"cure-api2.ncats.io/v1/drugs/7425","rxNorm_id":null,"notes":null},"use_drug":[{"id":11839,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13335},{"id":11840,"answer":"In a novel combination with another drug","answer_other":"","regimen":13335}],"created":"2020-12-02T22:59:53.430183Z","updated":"2020-12-02T23:12:46.008596Z","dose":"50mg","frequency":"TID","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6663}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8744,"answer":"Clinical assessment","answer_other":"","report":6663}],"how_diagnosis":[{"id":15032,"answer":"Clinical assessment","answer_other":"","report":6663},{"id":15033,"answer":"Imaging","answer_other":"","report":6663},{"id":15034,"answer":"PCR","answer_other":"","report":6663}],"author_username":"Paige Evans","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Nurse","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4851,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6663},{"id":4852,"answer":"Unusual disease presentation","answer_other":"","report":6663}],"adverse_event_outcome":[{"id":90,"answer":"Hospitalization (initial or prolonged)","report":6663},{"id":91,"answer":"Required Intervention to Prevent Permanent Impairment/Damage","report":6663}],"is_author":false,"cross_linked_diseases":[{"id":550,"name":"Respiratory Tract Infections"}],"races":[],"created":"2020-12-02T22:51:37.225139Z","updated":"2020-12-02T23:12:45.975549Z","title":"Hydroxychloroquine-induced Stevens-Johnson syndrome in COVID-19: a rare case report.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32617169,"doi":"10.1093/omcr/omaa042","article_url":"https://pubmed.ncbi.nlm.nih.gov/32617169/","pub_year":2020,"published_authors":"Davoodi L\r\nJafarpour H\r\nKazeminejad A\r\nSoleymani E\r\nAkbari Z\r\nRazavi A","article_author_email":"razavialireza33@gmail.com","journal":"Oxford medical case reports","abstract":"The international outbreak of respiratory illness termed coronavirus disease 2019 (COVID-19) began in December 2019 that has affected >0.8 million individuals. Self-limiting respiratory tract involvement, severe pneumonia, multiorgan failure and death are the spectrum of COVID-19. To date, there are no especial therapeutic agents for COVID-19 infections. One such medication includes the antimalarial hydroxychloroquine (HCQ), which recently reported as a possible therapy for shortening the duration of COVID-19 symptoms, reducing inflammatory reactions to infection, impairing the exacerbation of pneumonia and boosting lung imaging findings. Like all medications, HCQ has side effects and may occur in COVID-19 patients. Here, we report on the case of a 40-some-old woman, presented with fever and dry cough, who had COVID-19 and 2 days later presented with a pruritic erythematous maculopapular rash, which started from the distal of upper extremities and rapidly, involved the entire body.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"41-50 years","sex":"Female","ethnicity":null,"country_contracted":"Iran, Islamic Republic of","country_treated":"Iran, Islamic Republic of","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lungs, Skin","clinical_syndrome":"Respiratory tract infection, fever, dry cough, maculopapular rash and flat atypical targets diagnosed as Stevens-Johnson syndrome","severity":null,"prev_treatment":"","unusual":"A diagnosis of Stevens-Johnson syndrome as an adverse event of Hydroxychloroquine treatment for COVID-19.","drug_treatment_features":"","have_adverse_events":true,"adverse_events":"After two days of Hydroxychloroquine treatment , the patient presented with a pruritic erythematous maculopapular rash and flat atypical targets that started fromthe distal of upper extremities, rapidly involved the entire body and torn blisters that were only be seen as ulcers on orolabial area.\r\n\r\nThis adverse event was diagnosed as Stevensâ€“Johnson syndrome (SJS).","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"Patient was discharged after five days with nonpruritic scalded skin on the distal of upper extremities","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[5600,7425,8342,8783,8787]}]